Broad New China Policies Aim To Improve Market Access

Expanded Exclusivity Among Proposals

 
• By Xu Hu

China’s State Council has released a wide-ranging set of policy incentives intended to eliminate regulatory barriers and improve market access for innovative drugs.

China's policy incentives for biopharma development
China's State Council on 3 January released a series of encouraging measures for reforms and quality development in the biopharma sector. (Shutterstock)
Xu Hu

Read more by Xu Hu

Xu is a senior reporter and covers aspects on policy and regulations in China pharma industry within the APAC Pharma news team.

More from China

More from Market Access